DENND4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.648800E-01
Normal-vs-Stage2
3.774200E-01
Normal-vs-Stage3
3.009000E-01
Normal-vs-Stage4
3.821800E-01
Stage1-vs-Stage2
7.474400E-01
Stage1-vs-Stage3
5.488000E-02
Stage1-vs-Stage4
8.724400E-01
Stage2-vs-Stage3
8.525600E-02
Stage2-vs-Stage4
9.506200E-01
Stage3-vs-Stage4
2.976000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.753800E-01
Normal-vs-AfricanAmerican
3.734600E-01
Normal-vs-Asian
3.563400E-01
Caucasian-vs-AfricanAmerican
8.822600E-01
Caucasian-vs-Asian
5.140800E-01
AfricanAmerican-vs-Asian
4.430800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.718000E-01
Normal-vs-Female
3.761000E-01
Male-vs-Female
7.718000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.817200E-01
Normal-vs-Age(41-60Yrs)
3.858800E-01
Normal-vs-Age(61-80Yrs)
3.684400E-01
Normal-vs-Age(81-100Yrs)
3.642600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.261400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.359000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.811400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.409800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.587000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.699000E-01
Normal-vs-Daily Drinker
3.470400E-01
Normal-vs-Weekly Drinker
3.815800E-01
Normal-vs-Occasional Drinker
3.767000E-01
Normal-vs-Social Drinker
3.816600E-01
Non Drinker-vs-Daily Drinker
4.245800E-01
Non Drinker-vs-Weekly Drinker
7.464400E-01
Non Drinker-vs-Occasional Drinker
8.319600E-01
Non Drinker-vs-Social Drinker
6.600200E-01
Daily Drinker-vs-Weekly Drinker
2.141800E-01
Daily Drinker-vs-Occasional Drinker
2.530000E-01
Daily Drinker-vs-Social Drinker
1.520990E-01
Weekly Drinker-vs-Occasional Drinker
8.800800E-01
Weekly Drinker-vs-Social Drinker
9.854800E-01
Occasional Drinker-vs-Social Drinker
8.485000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.014800E-01
Normal-vs-Grade 2
8.013400E-01
Normal-vs-Grade 3
8.008200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.399800E-01
Grade 1-vs-Grade 3
9.482200E-01
Grade 1-vs-Grade 4
6.014800E-01
Grade 2-vs-Grade 3
9.880800E-01
Grade 2-vs-Grade 4
8.013400E-01
Grade 3-vs-Grade 4
8.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.667000E-01
Normal-vs-NonDiabetic
3.715200E-01
Diabetic-vs-NonDiabetic
7.933200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.607200E-01
Normal-vs-NoPancreatitis
3.700600E-01
Pancreatitis-vs-NoPancreatitis
5.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.818600E-01
Normal-vs-N1
3.704800E-01
N0-vs-N1
5.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.049600E-01
Normal-vs-TP53-NonMutant
3.377000E-01
TP53-Mutant-vs-TP53-NonMutant
9.398100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
